Indivior Pharmaceuticals (INDV) Debt Ratio (2021 - 2026)

Indivior Pharmaceuticals' Debt Ratio history runs 6 years deep, the most recent figure standing at 0.41 for Q1 2026.

• In Q1 2026, Debt Ratio rose 69.69% year-over-year to 0.41; the TTM figure through Mar 2026 stood at 0.41 (up 69.69% YoY), while the FY2025 annual figure was 0.27, up 4.97% from the prior year.
• Debt Ratio was 0.41 for Q1 2026 at Indivior Pharmaceuticals, up from 0.27 in the prior quarter.
• In the past five years, Debt Ratio ranged from a high of 0.41 in Q1 2026 to a low of 0.14 in Q4 2022.
• Historically, Debt Ratio has averaged 0.24 across 5 years, with a median of 0.23 in 2025.
• The sharpest annual moves came in 2023 and 2024: Debt Ratio increased 0.63% in 2023, then soared 85.35% in 2024.
• A 5-year view of Debt Ratio shows it stood at 0.14 in 2022, then climbed by 0.63% to 0.14 in 2023, then surged by 85.35% to 0.25 in 2024, then grew by 4.97% to 0.27 in 2025, then surged by 52.86% to 0.41 in 2026.
• The last three Debt Ratio figures came in at 0.41 (Q1 2026), 0.27 (Q4 2025), and 0.23 (Q3 2025), per Business Quant data.